Obstetrics & Gynecology Doctors in Broomall, PA Accepting Medicare

7 Obstetrics & Gynecology doctors found. Showing 1 - 7

Dr. Randolph P. Heinzel, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1991 Sproul Rd, Suite 200, Broomall, PA 19008 Phone: 610-325-1350    Fax: 610-325-1357

Beverly Ann Eisenhuth, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1991 Sproul Rd, Suite 200, Broomall, PA 19008 Phone: 610-325-1350    Fax: 610-325-1357

Dr. Rudolf L Laveran-stiebar, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1991 Sproul Rd, Suite 200 Main Line Health Center, Broomall, PA 19008 Phone: 610-325-1350    Fax: 610-325-1357

Dr. Edwina Navasha Coleman, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1991 Sproul Rd Ste 300, Broomall, PA 19008 Phone: 610-325-1390    Fax: 610-325-1373

Courtney B Hammerel, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1991 Sproul Rd, Suite 200, Broomall, PA 19008 Phone: 610-325-1350    Fax: 610-325-1357

Dr. Eva Marie Martin, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1991 Sproul Rd Ste 200, Broomall, PA 19008 Phone: 610-325-1350    Fax: 610-325-3518

Dr. Sharon F Rudo, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1991 Sproul Rd, Suite 200, Broomall, PA 19008 Phone: 610-325-1350    Fax: 610-325-1357

News Archive

Metastatic site impacts survival in targeted RCC treatment

Bone and liver metastases may have the heaviest impact on the survival of patients receiving targeted therapy for metastatic renal cell carcinoma, suggest data from the International Metastatic Renal Cell Carcinoma Database Consortium.

Quality of life after treatment for head and neck cancer associated with longer-term survival

Several studies have provided evidence that quality of life (QOL) might be associated with long-term survival in cancer patients, according to background information in the article.

Radical regulatory reform for life science industries needs to be a priority: Researchers

This declining trend is blamed on a failure of innovative drive in the industry, failure of the UK to support basic research, failure of venture capital to invest in early stage research, or failure of the Health Service to provide smart procurement.

Patients new to chronic disease medication face risk of medication discontinuation, finds study

In a new study published online today by Clinical Therapeutics, researchers from Adheris, Inc., an inVentiv Health company, found that patients new to chronic disease medication face the greatest risk of medication discontinuation during the first 30 days of treatment—with rates of discontinuation ranging from 29.6% to 78.1%.

Read more Medical News

› Verified 1 days ago